ArticleBiomedicines2022

Molecular Mechanisms Linking Empagliflozin to Renal Protection in the LLC-PK1 Model of Diabetic Nephropathy.

Vjera Mihaljević et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.